News

Heart Metabolics Announces Initiation of Phase 2B Study of Perhexiline for Hypertrophic Cardiomyopat
Posted: 2016-08-31 in Press Releases

Global Kinetics Corporation Announces New President and CEO
Posted: 2016-08-30 in Press Releases

Osprey Medical Announces Oversubscribed A$28 Million Private Placement
Posted: 2016-08-04 in Press Releases

Brandon Capital Partners expands into New Zealand with AU$200 million life science fund
Posted: 2016-07-26 in Press Releases

Osprey Medical Inc. Quarterly Cash Flow Report July '16
Posted: 2016-07-20 in Press Releases

Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02)
Posted: 2016-07-20 in Press Releases

Key Sales Milestones
Posted: 2016-07-07 in Press Releases

Auspherix Appoints Experienced Anti-Infectives Clinician to Scientific Advisory Board
Posted: 2016-07-04 in Press Releases

Nexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis
Posted: 2016-05-26 in Press Releases

DyeVert Pilot Trial Results Presented at EuroPCR
Posted: 2016-05-20 in Press Releases